These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38320161)

  • 1. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.
    Smith BL; Hunt KK; Carr D; Blumencranz PW; Hwang ES; Gadd MA; Stone K; Dyess DL; Dodge D; Valente S; Dekhne N; Clark P; Lee MC; Samiian L; Lesnikoski BA; Clark L; Smith KP; Chang M; Harris DK; Schlossberg B; Ferrer J; Wapnir IL
    NEJM Evid; 2023 Jul; 2(7):EVIDoa2200333. PubMed ID: 38320161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.
    Hwang ES; Beitsch P; Blumencranz P; Carr D; Chagpar A; Clark L; Dekhne N; Dodge D; Dyess DL; Gold L; Grobmyer S; Hunt K; Karp S; Lesnikoski BA; Wapnir I; Smith BL;
    JAMA Surg; 2022 Jul; 157(7):573-580. PubMed ID: 35544130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Smith BL; Lanahan CR; Specht MC; Kelly BN; Brown C; Strasfeld DB; Ferrer JM; Rai U; Tang R; Rice-Stitt T; Biernacka A; Brachtel EF; Gadd MA
    Ann Surg Oncol; 2020 Jun; 27(6):1854-1861. PubMed ID: 31898104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
    Smith BL; Gadd MA; Lanahan CR; Rai U; Tang R; Rice-Stitt T; Merrill AL; Strasfeld DB; Ferrer JM; Brachtel EF; Specht MC
    Breast Cancer Res Treat; 2018 Sep; 171(2):413-420. PubMed ID: 29948401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.
    Schnabel F; Boolbol SK; Gittleman M; Karni T; Tafra L; Feldman S; Police A; Friedman NB; Karlan S; Holmes D; Willey SC; Carmon M; Fernandez K; Akbari S; Harness J; Guerra L; Frazier T; Lane K; Simmons RM; Estabrook A; Allweis T
    Ann Surg Oncol; 2014 May; 21(5):1589-95. PubMed ID: 24595800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single institution's randomized double-armed prospective study of lumpectomy margins with adjunctive use of the MarginProbe in nonpalpable breast cancers.
    Geha RC; Taback B; Cadena L; Borden B; Feldman S
    Breast J; 2020 Nov; 26(11):2157-2162. PubMed ID: 32772474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Lumpectomy and Cavity Shave Margin Status on Recurrence and Survival in Breast-Conserving Surgery.
    Abdelsattar JM; Afridi FG; Dai Z; Yousaf N; Seldomridge A; Battin AO; Wen S; Gray D; Marsh JW; Cowher MS; Partin JF; Hazard-Jenkins H; Lupinacci K
    Am Surg; 2023 Mar; 89(3):424-433. PubMed ID: 34196595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.
    Morrow M; Abrahamse P; Hofer TP; Ward KC; Hamilton AS; Kurian AW; Katz SJ; Jagsi R
    JAMA Oncol; 2017 Oct; 3(10):1352-1357. PubMed ID: 28586788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.
    Osako T; Nishimura R; Nishiyama Y; Okumura Y; Tashima R; Nakano M; Fujisue M; Toyozumi Y; Arima N
    Int J Clin Oncol; 2015 Dec; 20(6):1093-101. PubMed ID: 25855313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial.
    García-Tejedor A; Guma A; Soler T; Valdivieso A; Petit A; Contreras N; Chappuis CG; Falo C; Pernas S; Amselem A; Plà MJ; Fernández-Montolí E; Burdío F; Ponce J
    Radiology; 2018 Nov; 289(2):317-324. PubMed ID: 30129904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins.
    Cox CE; Pendas S; Ku NN; Reintgen DS; Greenberg HS; Nicosia SV
    Am Surg; 1998 Jun; 64(6):533-7; discussion 537-8. PubMed ID: 9619174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of perioperative techniques to attain negative margins and spare healthy breast tissue in breast conserving surgery.
    Krishna KL; Srinath BS; Santosh D; Velusamy S; Divyamala KP; Sariya Mohammadi J; Kurpad V; Kulkarni S; Yaji P; Goud S; Dhanireddy S; Ram J
    Breast Dis; 2020; 39(3-4):127-135. PubMed ID: 32831188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
    Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Something to Dye For: Toward Better Breast Lumpectomy Margins.
    Turza LC; Shriver CD
    NEJM Evid; 2023 Jul; 2(7):EVIDe2300114. PubMed ID: 38320169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Three-Dimensional Helical CT Image-Guided Planning for Made-to-Order Lumpectomy in Breast Cancer Patients.
    Uematsu T; Sano M; Homma K; Sato N
    Breast J; 2004; 10(1):33-7. PubMed ID: 14717757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery.
    Tang R; Coopey SB; Specht MC; Lei L; Gadd MA; Hughes KS; Brachtel EF; Smith BL
    Am J Surg; 2015 Jul; 210(1):93-8. PubMed ID: 25613784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.